Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2012
09/20/2012WO2012122590A1 Antibody recognizing n-domain of midkine
09/20/2012WO2011005295A8 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
09/20/2012US20120238642 Polymer Mechanical Damping Composites and Methods of Production
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238630 Compositions comprising nonsteroidal anti - inflammatory drugs
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238626 Methods and compositions for promoting the respiratory development of an infant
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238587 Novel pyridopyrimidine derivatives and use thereof
09/20/2012US20120238582 Quinazoline derivatives
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238576 Triazine Derivatives and their Therapeutical Applications
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120238567 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/20/2012US20120238565 Triazolopyridine compounds and their use as ask inhibitors
09/20/2012US20120238561 Morpholinothiazoles as alpha 7 positive allosteric modulators
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238548 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238534 Oral suspension of prednisolone acetate
09/20/2012US20120237602 Press-coated orally-disintegrating tablets
09/20/2012US20120237601 Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt
09/20/2012US20120237587 Combination preparation including a corticosteroid and exosomes
09/20/2012US20120237570 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
09/20/2012US20120237569 Emulsified composition for dilution and cancer vaccine composition
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237553 Process to Obtain a Homeopathic Medicament and Use Thereof
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012US20120237551 Immune response modifier formulations containing oleic acid and methods
09/20/2012US20120237550 Maintaining Antibody-Binding Activity Of Immunosuppressant Drug Conjugates
09/20/2012US20120237549 Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
09/20/2012US20120237546 Compounds and compositions as tlr activity modulators
09/20/2012US20120237545 Assays for influenza virus hemagglutinins
09/20/2012US20120237544 Bacterial spore having therapeutic agent adsorbed on its surface
09/20/2012US20120237541 Novel use of l. undulata extract as therapeutics for allergic diseases
09/20/2012US20120237539 Method for making targeted therapeutic agents directed to soluble targets
09/20/2012US20120237538 RECOMBINANTLY EXPRESSED PLASMODIUM CelTOS ANTIGEN AND METHODS OF USE THEREOF
09/20/2012US20120237537 Methods for producing an immune response to tuberculosis
09/20/2012US20120237535 Therapeutic Compositions For The Treatment of HPV-Induced Diseases
09/20/2012US20120237516 Compositions and methods relating to anti-igf-1 receptor antibodies
09/20/2012US20120237515 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
09/20/2012US20120237513 Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells
09/20/2012US20120237510 Anti-NKG2A Antibodies and Uses Thereof
09/20/2012US20120237508 Fused amino pyridine as hsp90 inhibitors
09/20/2012US20120237480 2'allene-substituted nucleoside derivatives
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237472 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012DE102011015142A1 Agens zur Prophylaxe und Behandlung altersassoziierter Krankheiten und Störungen sowie zur Verlängerung der Lebensdauer Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as extending the life
09/20/2012CA2852056A1 Anti-cd40 antibodies and uses thereof
09/20/2012CA2850081A1 Isoxazolidine derivatives
09/20/2012CA2837348A1 Immunomodulatory agent, combinations, uses thereof and immunotherapy method for recontextualising, reprogramming and restoring immune system in real time
09/20/2012CA2830349A1 Re-directed immunotherapy
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2829982A1 Isoxazolidine derivatives
09/20/2012CA2829960A1 Listeria-based adjuvants
09/20/2012CA2829607A1 A method of vaccination comprising a histone deacetylase inhibitor
09/20/2012CA2829593A1 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases
09/20/2012CA2828657A1 Use of low dose il-2 for treating autoimmune - related or inflammatory disorders
09/20/2012CA2828622A1 Vaccine formulation of mannose coated peptide particles
09/20/2012CA2828518A1 Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk)
09/19/2012EP2500362A2 Humanized antibodies against TL1A
09/19/2012EP2500039A1 Oligomer-antihistamine conjugates
09/19/2012EP2500034A1 Therapeutic agent for psoriasis or atopic dermatitis
09/19/2012EP2499247A2 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity
09/19/2012EP2499146A1 Tricyclic pyrazol amine derivatives
09/19/2012EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499141A2 Polymorphs of nevirapine and method for increasing the solubility of a transcriptase inhibitor composition
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012EP2498822A1 Conjugate molecule
09/19/2012EP2498816A1 Non-dna base-containing polynucleotide compositions and their use for the modulation of immune responses
09/19/2012EP2498808A2 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
09/19/2012EP1666481B1 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
09/19/2012CN102686574A Coumarin compounds as receptor modulators with therapeutic utility
09/19/2012CN102686233A Composition for treating allergic diseases,using wheat bran extract or active ingredient isolated therefrom
09/19/2012CN102676535A Gene of zebra fish tumor necrosis factor 14 and cloning method and restructuring application thereof
09/19/2012CN102676396A Paecilomyces tenuipes strain and application thereof
09/19/2012CN102676349A Giant salamander bone healthcare wine and preparation method thereof
09/19/2012CN102675460A Anti-tumor necrosis factor alpha human-derived antibody
09/19/2012CN102675453A Adrenocorticotrophic hormone (ACTH) analogue, preparation method and application thereof
09/19/2012CN102675439A Preparation method and application of recombination ryegrass pollen allergen and mutant thereof
09/19/2012CN102675346A Levamisole organic acid salt, synthetic method for levamisole organic acid salt and medicinal composition of levamisole organic acid salt
09/19/2012CN102675316A Quinazoline purine derivative and application thereof in preparation of diabetes drugs
09/19/2012CN102675289A Novel N-phenyl benzamide derivative serving as protein kinase inhibitor
09/19/2012CN102675286A Indazoles compound, and preparation method and application thereof, and medical composition
09/19/2012CN102675281A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/19/2012CN102675244A Thiazine amide derivative and application thereof in preparation of medicines for preventing and controlling neurodegenerative diseases
09/19/2012CN102671197A Medical composite containing deoxidation phenylephrine
09/19/2012CN102671190A Enzymic preparations for improving human body immunity and enhancing gastrointestinal and respiratory functions
09/19/2012CN102671069A Medicinal composition for treating allergic rhinitis
09/19/2012CN102671033A Traditional Chinese medicine composition for improving sleep and strengthening organism immunity, and clinical preparation thereof
09/19/2012CN102671009A A fermented plant extract, fermented plant extract powder and manufacture method of a composition containing the fermented plant extract
09/19/2012CN102671006A Traditional Chinese medicine prescription for treating systemic lupus erythematosus nephritis
09/19/2012CN102670999A Prescription of dendrobium nobile pills and processing process thereof
09/19/2012CN102670991A Preparation method for dendrobium nobile extractum
09/19/2012CN102670935A Method for extracting total saponins from allium chinense
09/19/2012CN102670930A Chinese decoction for treating allelgic asthma
09/19/2012CN102670917A Composite enzyme and its preparation method
1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 1172